North America Tumor Ablation Market Share, Size, Trends, Industry Analysis Report, By Technology (Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation, Others); By Mode of Treatment; By Application; By Region; Segment Forecast, 2024 - 2032
- Published Date:Mar-2024
- Pages: 116
- Format: PDF
- Report ID: PM4500
- Base Year: 2023
- Historical Data: 2019-2022
Report Outlook
North America tumor ablation market size was valued at USD 0.79 billion in 2023. The market is anticipated to grow from USD 0.88 billion in 2024 to USD 2.12 billion by 2032, exhibiting the CAGR of 11.6% during the forecast period
North America Tumor Ablation Market Overview
The increasing prevalence of cancer, rising incidences of smoking, and sedentary lifestyle will drive the tumor ablation market growth in North America due to high purchasing power parity, availability of reimbursement, and government support for quality healthcare.
The market is anticipated to grow in North America due to an increase in the number of cancer patients and technological advancements in tumor ablation equipment that offer accuracy, cost-effectiveness, and mobility. The rising incidence of cancer and the high demand for safe therapeutic options will also contribute to the growth of the market in the region.
To Understand More About this Research:Request a Free Sample Report
Tumor ablation is a medical procedure that is used to treat tumors, which are abnormal masses of tissue that can develop in various parts of the body. The process of ablation involves destroying or removing the tumor using different methods, such as cold (cryoablation), heat (radiofrequency ablation), or other energy sources.
- For instance, in April 2023, Ethicon, a Johnson & Johnson MedTech Company, treated the first North American patient in its POWER1 study, utilizing robot-assisted transbronchial microwave ablation for lung cancer, aiming to demonstrate safety and efficacy in collaboration with global thoracic oncology centers.
The heightened awareness of tumor ablation procedures and the enlargement of medical centers in North America facilitate the growth of the market. The surging innovations and the adoption of advanced technologies for surgical methods and devices will offer beneficial opportunities for the growth of the market.
The COVID-19 pandemic has had a significant impact on the North American tumor ablation market development. The U.S. and Canada are the majorly affected countries by Coronavirus. In the initial phase of the pandemic, healthcare services were affected, leading to the postponement or cancelation of elective procedures, including some tumor ablation treatments. This was necessary to prioritize resources for COVID-19 cases.
Thus, the North American tumor ablation market demand experienced a temporary decline during the COVID-19 pandemic. However, elective surgeries were canceled or delayed, resulting in a decrease in tumor ablation procedures in North America, which impacted the region's tumor ablation equipment and accessories market.
North America Tumor Ablation Market Dynamics
Market Drivers
- Increasing prevalence of cancer will drive the growth of the market
The rising prevalence of cancer will drive the growth of the market in North America. Tumor Ablation is a technique used to remove tumors without completely getting rid of them. Patients who undergo this treatment have lower hospitalization rates and are more likely to use ablation systems. With the increasing prevalence of prostate cancer, colon cancer, lung cancer, and breast cancer in North America, the demand for tumor ablation technologies is anticipated to rise. These technologies are particularly used to treat kidney, soft tissue, liver, and bone tumors.
The National Cancer Institute reported around 1,806,590 newly diagnosed cancer cases in the year 2020 in the United States, while the American Cancer Society stated that 1.8 million new malignancies were identified in the country. This rise in cancer cases in the United States is anticipated to boost the demand for tumor ablation devices.
Market Restraints
- High cost associated with tumor ablation procedures hindering the growth of the market
The North America tumor ablation market has faced a significant hindrance due to the high costs associated with these procedures. Despite recent advancements in medical technology and increasing demand for minimally invasive treatments, the expenses involved in tumor ablation have posed a major challenge. Tumor ablation involves the targeted destruction of cancerous cells using techniques such as radiofrequency ablation, microwave ablation, and cryoablation. These procedures require sophisticated equipment, highly skilled medical professionals, and specialized facilities.
Furthermore, the high costs of tumor ablation procedures also include pre-operative and post-operative care, follow-up appointments, and necessary medications. These factors contribute to the overall financial burden for patients seeking tumor ablation as a treatment option. Additionally, insurance coverage for these procedures may vary, further limiting access to tumor ablation for some individuals.
Report Segmentation
The market is primarily segmented based on technology, mode of treatment, application, and region.
|
By Technology |
By Mode of Treatment |
By Application |
By Country |
|
|
|
|
To Understand the Scope of this Report:Speak to Analyst
North America Tumor Ablation Market Segmental Analysis
By Product Analysis
- The radiofrequency ablation segment held the largest market share in the North America tumor ablation market. Radiofrequency Ablation is an extensively utilized and effective technique in North America. This medical procedure involves using high-frequency electrical currents to generate heat and destroy cancerous tissues. It is minimally invasive and has gained popularity due to its precision in targeting tumors while sparing surrounding healthy tissues. RFA is widely used in treating various cancer types, including liver, lung, kidney, and bone tumors.
Radiofrequency ablation has become increasingly popular in North America due to its ability to offer a less invasive alternative to traditional surgical interventions. This results in less patient discomfort, shorter recovery times, and an overall improved quality of life. Additionally, its outpatient-friendly nature aligns with the growing trend toward outpatient care, contributing to radiofrequency ablation's widespread acceptance as a valuable tool in the region's comprehensive approach to cancer treatment.
By Mode of Treatment Analysis
- The percutaneous ablation segment held the largest market share in the North America tumor ablation market. Percutaneous ablation delivers fast recovery, better security, and less scarring. Furthermore, factors like patient convenience and cost-efficiency are anticipated to drive the percutaneous ablation demand higher in the North America region. Additionally, percutaneous ablation procedures can be performed on an outpatient basis, reducing the need for hospitalization and allowing patients to return to their daily activities sooner. Moreover, the cost-effectiveness of percutaneous ablation compared to other treatment options makes it a preferred choice for both patients and healthcare providers in North America.
North America Tumor Ablation Market Regional Insights
- U.S. dominated the tumor ablation market in 2023
The U.S. dominated the tumor ablation market. The advanced healthcare infrastructure, rise in the occurrence of numerous types of cancers, surging inclination of patients towards cancer treatment, and the funds received from the government for cancer research will bolster the growth of the market in North America. Also, the increasing rate of obesity and the rising geriatric population are anticipated to drive the adoption of diagnosis and cancer therapies.
This technique is extensively utilized in North America for treating liver, kidney, lung, and prostate tumors. The technique is popular due to its ability to remove cancerous tissue while preserving healthy organs and tissues.
Competitive Landscape
The North America tumor ablation market is fragmented and is anticipated to witness competition due to several players' presence. Major service providers in the market are constantly upgrading their technologies to stay ahead of the competition and to ensure efficiency, integrity, and safety. These players focus on partnership, product upgrades, and collaboration to gain a competitive edge over their peers and capture a significant market share.
Some of the major players operating in the market include:
- AngioDynamics Inc.
- Bioventus Inc.
- Boston Scientific Corp.
- EDAP TMS S.A.
- Galil Medical Inc.
- HealthTronics
- Medtronic Plc.
- Mermaid Medical
- Misonix, Inc.
- Neuwave Medical, Inc.
- SonaCare Medical
Recent Developments
- In March 2023, AngioDynamics partnered with Minimax Medical to facilitate the global distribution of its array of products. The partnership contains the international distribution of Minimax Medical's advanced Radiofrequency Ablation System, specifically designed for treating tumors and nodules.
Report Coverage
The North America tumor ablation market report emphasizes on key regions across the globe to provide better understanding of the product to the users. Also, the report provides market insights into recent developments, trends and analyzes the technologies that are gaining traction around the globe. Furthermore, the report covers in-depth qualitative analysis pertaining to various paradigm shifts associated with the transformation of these solutions.
The report provides detailed analysis of the market while focusing on various key aspects such as competitive analysis, technology, mode of treatment, application, and their futuristic growth opportunities.
North America Tumor Ablation Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2024 |
USD 0.88 billion |
|
Revenue forecast in 2032 |
USD 2.12 billion |
|
CAGR |
11.6% from 2024 – 2032 |
|
Base year |
2023 |
|
Historical data |
2019 – 2022 |
|
Forecast period |
2024 – 2032 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2024 to 2032 |
|
Segments covered |
By Technology, By Mode of Treatment, By Application, By Region |
|
Country scope |
U.S., Canada |
|
Customization |
Report customization as per your requirements with respect to countries, region and segmentation. |
FAQ's
North America Tumor Ablation Market Size Worth USD 2.12 Billion By 2032
The top market players in North America Tumor Ablation Market include AngioDynamics Inc., Bioventus Inc., Boston Scientific Corp., EDAP TMS S.A.
North America tumor ablation market exhibiting the CAGR of 11.6% during the forecast period
North America Tumor Ablation Market report covering key segments are on technology, mode of treatment, application, and region.
